Latest epilepsy Stories
New Results Presented at the 68th American Epilepsy Society (AES) Annual Meeting HOUSTON, Dec. 8, 2014 /PRNewswire/ -- Cyberonics, Inc.
Multiple Presentations Highlight Long-Term Safety, Tolerability, and Efficacy Measures, as Adjunctive Therapy for Patients with Refractory Partial-Onset Seizures SEATTLE, Dec.
Findings from Late-Breaking Abstract Demonstrate That Well-Defined Seizure Cluster Terminology is Necessary to Standardize Patient Diagnosis and Allow for Appropriate Treatment Strategies SEATTLE,
-- Primary efficacy and safety data from the largest Phase 3 brivaracetam study involving 768 patients presented at the 68th Annual Meeting of the American Epilepsy Society BRUSSELS, Dec.
-- Results of Investigational Studies of Perampanel and Rufinamide Accepted as Late-Breaking Posters -- WOODCLIFF LAKE, N.J., Dec. 5, 2014 /PRNewswire/ -- Eisai Inc.
MINNEAPOLIS, Dec. 5, 2014 /PRNewswire-USNewswire/ -- Today the Child Neurology Foundation (CNF), named Elizabeth A.
- Atlanta-based Collaboration Will Explore the Potential of Big Data to Help Inform Treatment Decisions for People Living with Epilepsy ATLANTA, Dec.
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.
Digital marketing agency promises $1,000 to students with epilepsy. ATLANTA, GA (PRWEB) November 26, 2014 EverSpark Interactive, a full service digital
- A woman chauffeur.
- A woman who operates an automobile.